Author Archives: Charles Moore

Imanova Receives More Medical Research Council Funding for MIND-MAPS Study

United Kingdom-based Imanova has received £1 million ($1.2 million U.S.) of strategic Medical Research Council (MRC) funding to clinically evaluate new positron emission tomography (PET) imaging tracers for measuring mitochondrial dysfunction and synaptic loss associated with Alzheimer’s and Parkinson’s diseases. Imanova previously had received a £0.5 million $623,000 U.S.) MRC grant…

Postive Trial Results of Elamipretide for Primary Mitochondrial Myopathy Reported by Stealth

Boston, Massachusetts-based clinical-stage biopharma Stealth BioTherapeutics has released positive results from the MMPOWER Phase 2 trial, a double-blind, dose-ascending, placebo-controlled study investigating the safety, tolerability, and efficacy of its lead drug candidate elamipretide for treating primary mitochondrial myopathy (muscle weakness) in genetically confirmed mitochondrial disease patients. The trial evaluated…

Mitochondrial Medicine 2016 Symposium to Bring Science, Clincal, Patient Communities Together in Seattle

The Pittsburgh, Penn. based United Mitochondrial Disease Foundation (UMDF) will celebrate its 20th anniversary at the Mitochondrial Medicine 2016 Symposium this week in Seattle, Wash., according to a press release provided to Mitochondrial Disease News. Currently recognized as the world’s foremost mitochondrial disease symposium, just 10 years ago the UMDF…

High-Resolution 3D Images Reveal Muscle Mitochondrial Power Grid

Findings of a new study are overturning longstanding scientific theories about how energy is distributed within muscles for powering movement. Researchers at the National Institutes of Health report the first clear evidence that muscle cells distribute energy primarily by the rapid conduction of electrical charges through a vast, interconnected network…